Imaging AI platform company HOPPR secured nearly $32 million in Series A funding to advance its infrastructure for building and deploying large-scale medical imaging AI models.
Key Details
- 1HOPPR, founded in 2019 and based in Chicago, focuses on AI infrastructure for medical imaging.
- 2The company announced nearly $32 million in Series A funding, led by Greycroft and Kivu Ventures.
- 3Its platform supports PACS vendors and software makers in developing clinical-grade AI applications.
- 4The new funds will accelerate platform development, expand foundation model capabilities, and grow the team.
- 5CEO Khan Siddiqui, MD, states the goal is to democratize access to high-performing, trustworthy imaging AI.
Why It Matters
This funding round enables HOPPR to scale its infrastructure, potentially accelerating the development and deployment of clinically robust AI tools in radiology. Broad access to such platforms could enhance diagnostic workflows, support radiologists, and improve patient care globally.
Source
Radiology Business
Related News
•Radiology Business
Harrison.ai Receives FDA Breakthrough Status for Imaging AI Device
Harrison.ai has been awarded three FDA breakthrough device designations for its imaging AI solutions, including a tool for obstructive hydrocephalus triage.
•Cardiovascular Business
FDA Authorizes AI Tool for Detecting Mitral Annular Calcification on Routine CT
Bunkerhill Health receives FDA clearance for an AI model that detects mitral annular calcification (MAC) on routine, non-gated CT scans.
•Radiology Business
Aidoc Receives FDA Breakthrough Status for Multi-Condition CT AI Triage
Aidoc has received FDA Breakthrough Device status for its AI solution that flags multiple critical conditions in CT scans.